{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:17:50Z","timestamp":1783466270581,"version":"3.55.0"},"reference-count":79,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sanofi"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Patients with cancer can be immunocompromised because of their disease and\/or due to anticancer therapy. In this population, severe influenza virus infections are associated with an elevated risk of morbidity and mortality. Influenza vaccination is therefore highly recommended in cancer patients, including those receiving anticancer therapy. However, vaccination coverage remains far below the recommended target for vulnerable subjects. Six specialists in oncology, hematology, immunology, and public health\/vaccinology convened with the objective of developing strategies, based on evidence and clinical experience, for improving influenza vaccination coverage in cancer patients. This viewpoint provides an overview of current influenza vaccination recommendations in cancer patients, discusses barriers to vaccination coverage, and presents strategies for overcoming said barriers. New immunization issues raised by the COVID-19 pandemic are also addressed. Future directions include improving public education on influenza vaccination, providing the media with accurate information, improving knowledge among healthcare professionals, improving access to vaccines for cancer patients, co-administration of the influenza and COVID-19 vaccines, increased collaboration between oncologists and other health professionals, increased accessibility of digital vaccination registries to specialists, shared information platforms, and promoting immunization campaigns by healthcare systems with the support of scientific societies.<\/jats:p>","DOI":"10.3390\/vaccines12040420","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T11:13:02Z","timestamp":1713265982000},"page":"420","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Improving Influenza Vaccination Coverage in Patients with Cancer: A Position Paper from a Multidisciplinary Expert Group"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2875-3744","authenticated-orcid":false,"given":"Paolo","family":"Bonanni","sequence":"first","affiliation":[{"name":"Department of Health Sciences, University of Florence, Viale G.B. Morgagni 48, 50134 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Maio","sequence":"additional","affiliation":[{"name":"Medical Oncology, Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy"},{"name":"Department of Oncology, Center for Immuno-Oncology, Azienda Ospedaliero Universitaria Senese, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8427-7765","authenticated-orcid":false,"given":"Giordano D.","family":"Beretta","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit Pescara Hospital, Via Fonte Romana 8, 65124 Pescara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8463-8487","authenticated-orcid":false,"given":"Giancarlo","family":"Icardi","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Genoa, Via Pastore 1, 16132 Genoa, Italy"},{"name":"Hygiene Unit, Ospedale Policlinico San Martino IRCCS Genoa, Largo Benzi 10, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rossi","sequence":"additional","affiliation":[{"name":"Giunta Esecutiva SIMG, Via del Sansovino 172, 50142 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Cinieri","sequence":"additional","affiliation":[{"name":"Medical Oncology and Breast Unit, Ospedale Perrino, S.S. 7 per Mesagne, 72100 Brindisi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Rodrigues, C.M.C., and Plotkin, S.A. (2020). Impact of vaccines; health, economic and social perspectives. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.01526"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/21645515.2017.1289301","article-title":"HPV vaccines: Global perspectives","volume":"13","author":"Gupta","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Lundstrom, K. (2024). COVID-19 vaccines: Where did we stand at the end of 2023?. Viruses, 16.","DOI":"10.20944\/preprints202401.0471.v1"},{"key":"ref_4","unstructured":"World Health Organization (2022, May 05). WHO Regional Office for Europe Recommendations on Influenza Vaccination for the 2021\/2022 Season during the Ongoing COVID-19 Pandemic. Available online: https:\/\/www.who.int\/europe\/publications\/i\/item\/WHO-EURO-2021-3920-43679-61434."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1080\/21645515.2018.1445446","article-title":"Seasonal Influenza Vaccine in Immunocompromised Persons","volume":"14","author":"Bosaeed","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4137\/CMO.S13774","article-title":"Influenza vaccination in cancer patients undergoing systemic therapy","volume":"8","author":"Shehata","year":"2014","journal-title":"Clin. Med. Insights Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/cncr.21203","article-title":"Epidemiology and outcomes of serious influenza-related infections in the cancer population","volume":"104","author":"Cooksley","year":"2005","journal-title":"Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/annonc\/mdu114","article-title":"Vaccination for seasonal influenza in patients with cancer: Recommendations of the Italian Society of Medical Oncology (AIOM)","volume":"25","author":"Pedrazzoli","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e12817","DOI":"10.1111\/ecc.12817","article-title":"Update of the recommendations of the Italian Society of Medical Oncology on vaccination for seasonal influenza and pneumococcal infection in patients with cancer: Focus on prevention of pneumonia","volume":"27","author":"Pedrazzoli","year":"2018","journal-title":"Eur. J. Cancer Care"},{"key":"ref_10","unstructured":"Pedrazzoli, P., Baldanti, F., Cinieri, S., and Bersanelli, M. (2022, May 05). Raccomandazioni per la Vaccinazione Antinfluenzale e Antipneumococcica in Oncologia. Available online: https:\/\/www.aiom.it\/wp-content\/uploads\/2021\/01\/2021_Racc_vacc_antiinfluenzale_AIOM_agg.pdf."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"100548","DOI":"10.1016\/j.esmoop.2022.100548","article-title":"Vaccination for herpes zoster in patients with solid tumors: A position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM)","volume":"7","author":"Pedrazzoli","year":"2022","journal-title":"ESMO Open"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"101215","DOI":"10.1016\/j.esmoop.2023.101215","article-title":"Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: Recommendations of the Associazione Italiana di Oncologia Medica (AIOM)","volume":"8","author":"Pedrazzoli","year":"2023","journal-title":"ESMO Open"},{"key":"ref_13","unstructured":"European Centre for Disease Prevention and Control (2022, May 05). Seasonal Influenza Vaccination and Antiviral Use in EU\/EEA Member States. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/seasonal-influenza-vaccination-antiviral-use-eu-eea-member-states."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2217\/imt-2018-0080","article-title":"Influenza Vaccine Indication during therapy with Immune checkpoint inhibitors: A transversal challenge. The INVIDIa study","volume":"10","author":"Bersanelli","year":"2018","journal-title":"Immunotherapy"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2478\/ahem-2023-0019","article-title":"Vaccination against influenza and attitudes towards seasonal vaccination of medical students from the Medical University of Silesia","volume":"77","author":"Wojczyk","year":"2023","journal-title":"Postepy Hig. Med. Dosw."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ng, Q.X., Lee, D.Y.X., Ng, C.X., Yau, C.E., Lim, Y.L., and Liew, T.M. (2023). Examining the negative sentiments related to influenza vaccination from 2017 to 2022: An unsupervised deep learning analysis of 261,613 Twitter posts. Vaccines, 11.","DOI":"10.3390\/vaccines11061018"},{"key":"ref_17","unstructured":"Ministero della Salute (2024, March 18). Vaccination Calendar, (In Italian)."},{"key":"ref_18","unstructured":"Ministero della Salute (2024, March 18). Prevention and Control of Influenza: Recommendations for the 2023\u20132024 Season, (In Italian)."},{"key":"ref_19","unstructured":"Ministero della Salute (2024, March 18). Communication Campaign on Vaccination against COVID and Seasonal Flu, (In Italian)."},{"key":"ref_20","unstructured":"World Health Organization (2022). Vaccines against influenza: WHO Position Paper\u2014May 2022. Wkly Epidemiol. Rec., 97, 185\u2013208."},{"key":"ref_21","unstructured":"World Health Organization (2022, August 02). Global Influenza Programme: Recommendations for Influenza Vaccine Composition. Available online: https:\/\/www.who.int\/teams\/global-influenza-programme\/vaccines\/who-recommendations."},{"key":"ref_22","unstructured":"Council of the European Union (2024, March 18). Council Recommendation of 22 December 2009 on Seasonal Influenza Vaccination (Text with EEA Relevance). Available online: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX%3A32009H1019&qid=1649670283539."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/femsre\/fuv039","article-title":"Influenza A virus transmission via respiratory aerosols or droplets as it relates to pandemic potential","volume":"40","author":"Richard","year":"2016","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_24","unstructured":"World Health Organization (2024, January 25). Estimating Disease Burden of Influenza. Available online: https:\/\/www.who.int\/europe\/activities\/estimating-disease-burden-of-influenza."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: A modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41375-020-01016-0","article-title":"Recommendations for vaccination in multiple myeloma: A consensus of the European Myeloma Network","volume":"35","author":"Ludwig","year":"2021","journal-title":"Leukemia"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2015.10.012","article-title":"Immunological effects of conventional chemotherapy and targeted anticancer agents","volume":"28","author":"Galluzzi","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3324\/haematol.2021.279512","article-title":"Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies","volume":"107","author":"Kuter","year":"2022","journal-title":"Haematologica"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ircmb.2023.03.002","article-title":"Radio-induced lymphopenia in the era of anti-cancer immunotherapy","volume":"378","author":"Meziani","year":"2023","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejca.2016.08.015","article-title":"Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology","volume":"67","author":"Berger","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e000968","DOI":"10.1136\/esmoopen-2020-000968","article-title":"Influenza in hospitalised patients with malignancy: A propensity score matching analysis","volume":"5","author":"Li","year":"2020","journal-title":"ESMO Open"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ccm.2016.12.005","article-title":"Bacterial pneumonia in patients with cancer: Novel risk factors and management","volume":"38","author":"Wong","year":"2017","journal-title":"Clin. Chest Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccc.2020.09.001","article-title":"Infectious disease complications in patients with cancer","volume":"37","author":"Seo","year":"2021","journal-title":"Crit. Care Clin."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s15010-022-01852-5","article-title":"Mortality in cancer patients with SARS-CoV-2 or seasonal influenza: An observational cohort study from a German-wide hospital network","volume":"51","author":"Kodde","year":"2023","journal-title":"Infection"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/j.clinthera.2021.03.002","article-title":"Impact of influenza infection among adult and pediatric populations with hematologic malignancy and hematopoietic stem cell transplant: A systematic review and meta-analysis","volume":"43","author":"Atalla","year":"2021","journal-title":"Clin. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/irv.12704","article-title":"Influenza in patients with cancer after 2009 pandemic AH1N1: An 8-year follow-up study in Mexico","volume":"14","author":"Volkow","year":"2020","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_37","unstructured":"Health and Safety Executive (2022, February 07). Immunisation Guidelines: Immunisation of Immunocompromised Persons. Available online: https:\/\/www.hse.ie\/eng\/health\/immunisation\/hcpinfo\/guidelines\/chapter3.pdf."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1470-2045(21)00213-8","article-title":"Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: Interim analysis of a prospective observational study","volume":"22","author":"Monin","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/CVI.00021-11","article-title":"Comparative study of immune status to infectious agents in elderly patients with multiple myeloma, Waldenstrom\u2019s macroglobulinemia, and monoclonal gammopathy of undetermined significance","volume":"18","author":"Karlsson","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1007\/s00520-020-05384-2","article-title":"Efficacy of influenza vaccine (Fluvax) in cancer patients on treatment: A prospective single arm, open-label study","volume":"28","author":"Ayoola","year":"2020","journal-title":"Support. Care Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.annonc.2020.03.290","article-title":"Immunogenicity and safety of influenza vaccination in cancer patients receiving checkpoint inhibitors targeting PD-1 or PD-L1","volume":"31","author":"Bayle","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/infdis\/jis487","article-title":"Influenza vaccination for immunocompromised patients: Systematic review and meta-analysis by etiology","volume":"206","author":"Beck","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2217\/imt-2019-0180","article-title":"Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study","volume":"12","author":"Bersanelli","year":"2020","journal-title":"Immunotherapy"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e002619","DOI":"10.1136\/jitc-2021-002619","article-title":"INfluenza Vaccine Indication during therapy with Immune checkpoint inhibitors: A multicenter prospective observational study (INVIDIa-2)","volume":"9","author":"Bersanelli","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_46","first-page":"CD008983","article-title":"Influenza vaccines in immunosuppressed adults with cancer","volume":"2","author":"Bitterman","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1200\/JCO.19.00354","article-title":"Influenza vaccine effectiveness among patients with cancer: A population-based study using health administrative and laboratory testing data from Ontario, Canada","volume":"37","author":"Blanchette","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1001\/jama.2015.12160","article-title":"Association between hospitalization with community-acquired laboratory-confirmed influenza pneumonia and prior receipt of influenza vaccination","volume":"314","author":"Grijalva","year":"2015","journal-title":"JAMA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1158\/1078-0432.CCR-11-0253","article-title":"Cancer patients treated with sunitinib or sorafenib have sufficient antibody and cellular immune responses to warrant influenza vaccination","volume":"17","author":"Mulder","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/annonc\/mdr141","article-title":"Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and\/or targeted therapy: The VACANCE study","volume":"23","author":"Rousseau","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_51","unstructured":"The Academy of Medical Sciences (2022, May 05). COVID-19: Preparing for the Future. Looking Ahead to Winter 2021\/22 and Beyond. Available online: https:\/\/acmedsci.ac.uk\/file-download\/4747802."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.vaccine.2017.12.019","article-title":"How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008\/2009 to 2014\/2015","volume":"36","author":"Jorgensen","year":"2018","journal-title":"Vaccine"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1758835920968463","article-title":"Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: Prospective analysis from a multicentre observational trial by FICOG","volume":"12","author":"Bersanelli","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/cncr.33386","article-title":"Mortality in hospitalized patients with cancer and coronavirus disease 2019: A systematic review and meta-analysis of cohort studies","volume":"127","author":"Desai","year":"2021","journal-title":"Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(20)31187-9","article-title":"Clinical impact of COVID-19 on patients with cancer (CCC19): A cohort study","volume":"395","author":"Kuderer","year":"2020","journal-title":"Lancet"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e737","DOI":"10.1016\/S2352-3026(20)30251-9","article-title":"Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: A retrospective, multicentre, cohort study","volume":"7","author":"Passamonti","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejca.2021.07.038","article-title":"Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix","volume":"156","author":"Giacobini","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa2034201","article-title":"Interim results of a phase 1-2a trial of Ad26.COV2.S COVID-19 vaccine","volume":"384","author":"Sadoff","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ccell.2021.06.002","article-title":"Seroconversion rates following COVID-19 vaccination among patients with cancer","volume":"39","author":"Thakkar","year":"2021","journal-title":"Cancer Cell"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41571-021-00487-z","article-title":"COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials","volume":"18","author":"Desai","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/jama.2021.14131","article-title":"Influenza\u2019s unprecedented low profile during COVID-19 pandemic leaves experts wondering what this flu season has in store","volume":"326","author":"Rubin","year":"2021","journal-title":"JAMA"},{"key":"ref_62","unstructured":"European Centre for Disease Prevention and Control (2022, May 05). Interim Public Health Considerations for the Provision of Additional COVID-19 Vaccine Doses. Available online: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Interim-public-health-considerations-for-the-provision-of-additional-COVID-19-vaccine-doses.pdf."},{"key":"ref_63","unstructured":"Joint Committee on Vaccination and Immunisation (2022, May 05). JCVI Statement Regarding a COVID-19 Booster Vaccine Programme for Winter 2021 to 2022, Available online: https:\/\/www.gov.uk\/government\/publications\/jcvi-statement-september-2021-covid-19-booster-vaccine-programme-for-winter-2021-to-2022\/jcvi-statement-regarding-a-covid-19-booster-vaccine-programme-for-winter-2021-to-2022."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/S0140-6736(21)02329-1","article-title":"Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): A multicentre, randomised, controlled, phase 4 trial","volume":"398","author":"Lazarus","year":"2021","journal-title":"Lancet"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S2213-2600(21)00409-4","article-title":"Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: An exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial","volume":"10","author":"Toback","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_66","first-page":"168","article-title":"Seasonal influenza vaccination among cancer patients during the COVID-19 pandemic in Poland","volume":"25","author":"Bartoszkiewicz","year":"2021","journal-title":"Contemp. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10900-023-01277-7","article-title":"Changes in attitudes and barriers to seasonal influenza vaccination from 2007 to 2023","volume":"49","author":"Skyles","year":"2023","journal-title":"J. Community Health"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"839433","DOI":"10.3389\/fimmu.2022.839433","article-title":"Mind the \u201cvaccine fatigue\u201d","volume":"13","author":"Su","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Bengoa Terrero, C., Bas Villalobos, M., Rodriguez-Monino, A.P., Lasheras Carbajo, M.D., Perez-Villacastin, J., Garcia Torrent, M.J., Sanchez-Del-Hoyo, R., Bengoa San Sebastian, E., and Garcia Lledo, A. (2023). Effect of primary care center characteristics, healthcare worker vaccination status and patient economic setting on patient influenza vaccination coverage rates. Vaccines, 11.","DOI":"10.3390\/vaccines11061025"},{"key":"ref_70","unstructured":"World Health Organization (2022, September 22). Vaccine Hesitancy: A Growing Challenge for Immunization Programme. Available online: https:\/\/www.who.int\/news\/item\/18-08-2015-vaccine-hesitancy-a-growing-challenge-for-immunization-programmes."},{"key":"ref_71","unstructured":"World Health Organization (2022, September 22). Global Vaccine Action Plan 2011\u20132020. Available online: https:\/\/www.who.int\/publications\/i\/item\/global-vaccine-action-plan-2011-2020."},{"key":"ref_72","unstructured":"European Centre for Disease Prevention and Control (2022, September 22). Let\u2019s Talk about Hesitancy. Available online: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/media\/en\/publications\/Publications\/lets-talk-about-hesitancy-vaccination-guide.pdf."},{"key":"ref_73","first-page":"472","article-title":"Influenza vaccination coverage in patients treated with chemotherapy: Current clinical practice","volume":"71","author":"Wumkes","year":"2013","journal-title":"Neth. J. Med."},{"key":"ref_74","unstructured":"Istituto Superiore di Sanit\u00e0 (2024, March 18). 2023\u20132024 Recommendations for COVID-19 Vaccination. (In Italian)."},{"key":"ref_75","unstructured":"Ministero della Salute (2024, March 18). COVID-19 Vaccination Campaign 2023\/2024, (In Italian)."},{"key":"ref_76","unstructured":"Ministero della Salute (2024, March 18). Indications and Recommendations for the 2023\/2024 Autumn\/Winter Anti COVID-19 Vaccination Campaign, (In Italian)."},{"key":"ref_77","unstructured":"Ministero della Salute (2024, March 18). Integration of the Indications and Recommendations for the 2023\/2024 Autumn\/Winter Anti COVID-19 Vaccination Campaign, (In Italian)."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2195786","DOI":"10.1080\/21645515.2023.2195786","article-title":"Vaccine co-administration in adults: An effective way to improve vaccination coverage","volume":"19","author":"Bonanni","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_79","unstructured":"Hall, E., Wodi, A.P., Hamborsky, J., Morelli, V., and Schillie, S. (2021). Epidemiology and Prevention of Vaccine-Preventable Diseases, Public Health Foundation. [14th ed.]."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/4\/420\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:28:26Z","timestamp":1760106506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/4\/420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":79,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["vaccines12040420"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12040420","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,16]]}}}